Dublin, Ireland--(Newsfile Corp. - April 29, 2025) - Cosmo Pharmaceuticals N.V. (SIX: COPN) announces that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency ...
(RTTNews) - Cosmo Pharmaceuticals (COPN.SW) and Glenmark Pharmaceuticals (53229) announced on Monday that they have gained approval from the European Commission for Winlevi, which is a clascoterone ...
If you've experienced acne, you're probably familiar with the host of oral medications and topical products that promise to treat breakouts. There are the more common prescription-grade options — like ...
A decade-long battle with acne is one of the biggest reasons I became a beauty journalist. With over 50 million Americans dealing with this skin condition annually, it's a struggle that's near and ...
The first-in-class topical acne treatment targets the androgen receptor. The Food and Drug Administration (FDA) has approved Winlevi® (clascoterone cream 1%; Cassiopea) for the topical treatment of ...
ALBANY, N.Y.--(BUSINESS WIRE)--Albany Molecular Research, Inc. (AMRI) today announced that it has been named as the exclusive supplier of the active pharmaceutical ingredient (API) in Cassiopea SpA’s ...
Sun Pharmaceutical Industries Ltd on Tuesday said the Australian Therapeutic Goods Administration has granted regulatory approval for Winlevi cream indicated for the topical treatment of acne. The ...
Dublin, Ireland--(Newsfile Corp. - October 7, 2025) - Cosmo Pharmaceuticals N.V. (SIX: COPN), a global leader in AI-driven healthcare and specialty pharmaceuticals, today announced that the Ministry ...
WINLEVI (clascoterone cream 1% w/w) for male and female acne patients 12 years of age and older is now available in Canada. WINLEVI is the first and only topical Androgen Receptor Inhibitor, and the ...
WINLEVI is the first and only topical Androgen Receptor Inhibitor, and the newest Health Canada-approved formulation to target the hormonal component of acne in 40 years. WINLEVI may reduce sebum and ...
Lainate, Italy, November 3, 2021: Cassiopea SpA (SIX: SKIN), a specialty pharmaceutical company developing and preparing to commercialize prescription drugs with novel mechanisms of action (MOA) to ...
I've had acne-prone skin since I hit puberty. While it started as small, textured bumps, over the years the condition progressed to a combination of black and whiteheads that were always relatively ...